Arkadios Wealth Advisors’s Zimmer Biomet ZBH Stock Holding History

Arkadios Wealth Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$208K	Buy	2,304 +24	+1%	+$2.2K	﹤0.01%	1551
2025 Q4	$205K	Buy	+2,280	New	+$216K	﹤0.01%	1442
2021 Q4	–	Sell	-149	Closed	-$21K	–	1822
2021 Q3	$21K	Sell	149 -58	-28%	-$8.53K	﹤0.01%	1205
2021 Q2	$32K	Buy	207 +76	+58%	+$12.3K	﹤0.01%	1104
2021 Q1	$20K	Buy	131 +27	+26%	+$4.18K	﹤0.01%	973
2020 Q4	$15K	Buy	+104	New	+$14.7K	﹤0.01%	853

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arkadios Wealth Advisors's ZBH Position: Q1 2026 in Review

Arkadios Wealth Advisors increased its Zimmer Biomet (ZBH) stake by 1.1% in Q1 2026, buying an estimated $2.2K and bringing the position to 2,304 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #1551.

Arkadios Wealth Advisors first reported a position in ZBH in Q4 2020 and has held it in 6 quarters since. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Arkadios Wealth Advisors held 2,304 shares of Zimmer Biomet worth $208K as of Q1 2026.
Arkadios Wealth Advisors bought 24 Zimmer Biomet shares in Q1 2026, an estimated $2.2K.
Zimmer Biomet made up ﹤0.01% of Arkadios Wealth Advisors's portfolio in Q1 2026, its #1551 holding.
Arkadios Wealth Advisors first reported a position in Zimmer Biomet in Q4 2020 and has held it in 6 quarters since.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Arkadios Wealth Advisors's 13F filing for Q1 2026, filed 18 May 2026.